Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Mercer data shows 11% of large companies have dropped or plan to drop weight-loss coverage entirely, while 25% are adding new requirements this year
has received grant support from Aegerion Pharmaceuticals (manufacturer of metreleptin), Akcea Therapeutics, Ionis Pharmaceuticals, Regeneron Pharmaceuticals, Gemphire Therapeutics, Novo Nordisk, Rhythm Pharmaceuticals, Fractyl Health Laboratories, and GI Dynamics and has served as an advisor and/or a consultant to Aegerion Pharmaceuticals, Akcea Therapeutics, Ionis Pharmaceuticals, and Regeneron
External resources PMC: The physiology of weight loss plateaus during obesity pharmacotherapy , a comprehensive analysis of metabolic adaptation mechanisms during GLP-1 receptor agonist therapy, including appetite feedback coefficients and energy expenditure changes
Reverse Phase Protein Analysis of Mesenchymal Stem Cells from AML Patients and Healthy Donors Reveals Distinct Patterns of Protein Expression Reflecting Differences in Senescence, Differentiation and Survival Signaling
US$ 28.63
US$ 23.09
US$ 29.58
US$ 25.96
